IgM-Enriched Human Intravenous Immunoglobulin-Based Treatment of Patients With Early Donor Specific Anti-HLA Antibodies After Lung Transplantation.

about

Clinical Use and Therapeutic Potential of IVIG/SCIG, Plasma-Derived IgA or IgM, and Other Alternative Immunoglobulin Preparations.Update on Chronic Lung Allograft Dysfunction.

P2860

Q38820288-A66880FE-F934-4DFD-A134-7037096A1C90 Q41975571-A41543EC-4910-457D-BB97-FA1A51B26B55

P2860

IgM-Enriched Human Intravenous Immunoglobulin-Based Treatment of Patients With Early Donor Specific Anti-HLA Antibodies After Lung Transplantation.

Item

http://www.wikidata.org/entity/Q42364236

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

IgM-Enriched Human Intravenous ...... es After Lung Transplantation.

@en

IgM-Enriched Human Intravenous ...... es After Lung Transplantation.

@nl

type

Item

label

IgM-Enriched Human Intravenous ...... es After Lung Transplantation.

@en

IgM-Enriched Human Intravenous ...... es After Lung Transplantation.

@nl

prefLabel

IgM-Enriched Human Intravenous ...... es After Lung Transplantation.

@en

IgM-Enriched Human Intravenous ...... es After Lung Transplantation.

@nl

P1476

IgM-Enriched Human Intravenous ...... es After Lung Transplantation.

@en

P2093

Andreas Tecklenburg

http://www.w3.org/2001/XMLSchema#string

Carolin Erdfelder

http://www.w3.org/2001/XMLSchema#string

Christian Kühn

http://www.w3.org/2001/XMLSchema#string

Daniela Kieneke

http://www.w3.org/2001/XMLSchema#string

Fabio Ius

http://www.w3.org/2001/XMLSchema#string

Igor Tudorache

http://www.w3.org/2001/XMLSchema#string

Jan Kielstein

http://www.w3.org/2001/XMLSchema#string

Jawad Salman

http://www.w3.org/2001/XMLSchema#string

Jens Gottlieb

http://www.w3.org/2001/XMLSchema#string

Mark Greer

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation

Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation

Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria.

Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.

Post-transplant therapy with high-dose intravenous gammaglobulin: Applications to treatment of antibody-mediated rejection.

The emerging role of rituximab in organ transplantation.

Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective

Implications for human leukocyte antigen antibodies after lung transplantation: a 10-year experience in 441 patients.

Acute antibody-mediated rejection after lung transplantation.

Antibody-mediated rejection: treatment alternatives and outcomes.

P304

2682-2692

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/TP.0000000000001027

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Tobias Welte

Gregor Warnecke

Axel Haverich

P577

2015-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26714123

http://www.w3.org/2001/XMLSchema#string

P921

lung transplant

P932

5120772

http://www.w3.org/2001/XMLSchema#string

IgM-Enriched Human Intravenous Immunoglobulin-Based Treatment of Patients With Early Donor Specific Anti-HLA Antibodies After Lung Transplantation.

about

P2860

P2860

IgM-Enriched Human Intravenous Immunoglobulin-Based Treatment of Patients With Early Donor Specific Anti-HLA Antibodies After Lung Transplantation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932